收藏本站
我的資料
我的訂單
  購(gòu)物車 (0)  
親,您的購(gòu)物車空空的喲~
去購(gòu)物車結(jié)算
   
查看手機(jī)網(wǎng)站
其他賬號(hào)登錄: 注冊(cè) 登錄
150-21460884
產(chǎn)品分類
Tranilast trans- 
Tranilast trans-
收藏
|
|
英文名稱 : Tranilast trans-
貨號(hào) : EY-01Y15502
CAS : 70806-55-2
含量 : >98.00%
規(guī)格 : Free Sample (0.1-0.5 mg)、10mM*1mL in DMSO、10mg、50mg、100mg、200mg
品牌 : 上海一研
價(jià)格 :
0.00
購(gòu)買數(shù)量:
加入購(gòu)物車  立即購(gòu)買
產(chǎn)品保證
正品保證
快速發(fā)貨
產(chǎn)品詳情
產(chǎn)品評(píng)論(0)
銷售記錄(0)

產(chǎn)品屬性:


產(chǎn)品名稱

Tranilast trans-

規(guī)格

Free Sample (0.1-0.5 mg)、10mM*1mL in DMSO、10mg、50mg、100mg、200mg

貨號(hào)

EY-01Y15502

Cas No.: 70806-55-2

別名: N/A

化學(xué)名: N/A

分子式: C18H17NO5
GC37819.png
分子量: 327.33

溶解度: DMSO: 100 mg/mL (305.50 mM)

儲(chǔ)存條件: Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.

Shipping ConditionEvaluation sample solution : ship with blue ice

All other available size: ship with RT , or blue ice upon request

產(chǎn)品描述:


Tranilast (trans-) is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.Target: Angiotensin ReceptorTranilast has been approved in Japan and South Korea, since 1982, for the treatment of bronchial asthma, with indications for keloids and hypertrophic scar added in 1993. Tranilast is also used to treat asthma, autoimmune diseases, atopic and fibrotic pathologies, and can also inhibit angiogenesis. The antiproliferative properties of tranilast were found that tranilast elicited an inhibitory effect on fibroblast proliferation in vitro and also suppressed collagen production both in vitro and in vivo . Tranilast also reduced the release of chemical mediators from mast cells and suppressed hypersensitivity reactions. [1]Three-week-old C57Bl/10 and mdx mice received tranilast (~300 mg/kg) in their food for 9 weeks, after which fibrosis was assessed through histological analyses, and functional properties of tibialis anterior muscles were assessed in situ and diaphragm muscle strips in vitro. Tranilast administration did not significantly alter the mass of any muscles in control or mdx mice, but it decreased fibrosis in the severely affected diaphragm muscle by 31% compared with untreated mdx mice (P< 0.05) [2].[1]. Rogosnitzky, M., R. Danks, and E. Kardash, Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders. Anticancer Res, 2012. 32(7): p. 2471-8.

[2]. Swiderski, K., et al., Tranilast administration reduces fibrosis and improves fatigue resistance in muscles of mdx dystrophic mice. Fibrogenesis Tissue Repair, 2014. 7(1): p. 1.
特別提醒公司產(chǎn)品僅供科研使用


買家數(shù)量成交時(shí)間
正品保障

確保所有產(chǎn)品都是原裝正品

優(yōu)質(zhì)服務(wù)

優(yōu)質(zhì)服務(wù),售后無憂

安全包裝

統(tǒng)一包裝,保障產(chǎn)品安全運(yùn)輸

正規(guī)發(fā)票

機(jī)打發(fā)票,附箱送達(dá)

    配送方式            新手入門           售后服務(wù)           幫助中心           支付方式           關(guān)于我們
      包裝說明                會(huì)員服務(wù)                退款說明                服務(wù)協(xié)議               預(yù)付賬戶               聯(lián)系一研
      商品驗(yàn)收                積分規(guī)則               退換款地址            投訴建議                發(fā)票制度
      配送查詢                購(gòu)物流程                退換款流程            聯(lián)系客服               付款周期
      配送說明                會(huì)員體系                退換款原則            找回密碼               付款方式
手機(jī)掃一掃
訪問手機(jī)網(wǎng)站